Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-012357
Filing Date
2018-12-12
Accepted
2018-12-12 16:36:52
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1846252
2 filename2.htm EX-10.3 550358
3 filename3.htm EX-10.5 192984
4 GRAPHIC g621319dsp46.jpg GRAPHIC 34278
5 GRAPHIC g621319g17v32.jpg GRAPHIC 67381
6 GRAPHIC g621319g19m59.jpg GRAPHIC 65557
7 GRAPHIC g621319g28k84.jpg GRAPHIC 53502
8 GRAPHIC g621319g33v64.jpg GRAPHIC 63679
9 GRAPHIC g621319g34q10.jpg GRAPHIC 79079
10 GRAPHIC g621319g35u52.jpg GRAPHIC 28040
11 GRAPHIC g621319g39k02.jpg GRAPHIC 43535
12 GRAPHIC g621319g39p51.jpg GRAPHIC 32946
13 GRAPHIC g621319g40m16.jpg GRAPHIC 57367
14 GRAPHIC g621319g86t91.jpg GRAPHIC 76170
15 GRAPHIC g621319g91u13.jpg GRAPHIC 96087
16 GRAPHIC g621319g93f17.jpg GRAPHIC 59520
17 GRAPHIC g621319snap0008.jpg GRAPHIC 45879
  Complete submission text file 0000950123-18-012357.txt   3697317
Mailing Address 12651 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 858-333-6274
Cirius Therapeutics, Inc. (Filer) CIK: 0001702956 (see all company filings)

EIN.: 820928811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02309 | Film No.: 181231224
SIC: 2834 Pharmaceutical Preparations